History and progress of CD38 in myeloma

Share :
Published: 2 Nov 2016
Views: 2552
Rating:
Save
Dr Fabio Malavasi - University of Turin, Turin, Italy

Dr Malavasi talks to ecancertv at ICMM 2016 about his work looking at CD38 as a target in multiple myeloma.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.